Bristol Myers Squibb declares $0.54 quarterly dividend

Trending News 🌥️

Bristol-myers Squibb Intrinsic Value – BRISTOL-MYERS($NYSE:BMY): Bristol Myers Squibb has declared a $0.54/share quarterly dividend, in line with previous quarters. Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Dividends

The company has a history of paying dividends, with dividend per share of 2.11 USD for FY2022 Q2, and dividends of 2.01 USD and 1.84 USD paid in the last two years. Its dividend yields from 2020 to 2022 are 3.89%, 2.32% and 3.86%, resulting in a three-year average dividend yield of 3.36%. If you are looking for dividend stocks, Bristol Myers Squibb could be a good option to consider.

Share Price

On Wednesday, BRISTOL-MYERS SQUIBB stock opened at $70.5 and closed at $70.5, down by 0.8% from last closing price of 71.0. The company’s stock has been under pressure recently due to concerns about its blockbuster cancer drug, Opdivo. However, some analysts believe that the sell-off may be overdone and that the stock is a good value at current levels.

VI Analysis – Bristol-myers Squibb Intrinsic Value

The intrinsic value of a company’s shares is a reflection of its long-term potential. The VI app makes it easy to analyze a company’s fundamentals and calculate its intrinsic value. Based on the VI Line, the intrinsic value of BRISTOL-MYERS SQUIBB shares is around $75.6. The stock is currently trading at $70.5, which represents a fair price that is undervalued by 7%.

Summary

This is a relatively high dividend yield, which makes the stock an attractive investment for income investors. The company’s dividend history is also strong, with consistent increases over the past few years. Overall, Bristol Myers Squibb is a solid dividend stock that should be considered by income investors.